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Introduction
Anastomotic leakage is considered the Achilles heel after oeso-
phagogastric resection and its therapeutic management remains
a challenge. Different endoscopic options, such a clips, stents, in-
ternal drainage, fibrin glue instillation, or suturing devices, have
been suggested as minimally endoscopic therapies to treat these
complications. Recently, the use of endoscopic vacuum (E-Vac)
therapy has proven to be useful for the healing of these adverse
events and some studies have even reported its superiority to
other endoscopic devices [1]. The E-Vac promotes the growth of
granulation tissue and increases microcirculation while provid-
ing debridement of the cavity leak in each sponge replacement
by continuous negative pressure. We describe an exceptional
clinical scenario in which the use of the E-Vac allows the success-
ful closure of a cervical oesophagoileostomy leakage and the res-
olution of a mediastinal abscess after an ileum and right-colon
interposition for oesophageal replacement.
Case presentation
A 62-year-old man diagnosed in 2017 with a cT2N0M0 adenocar-
cinoma of the oesophagogastric junction underwent neoadjuvant
treatment with chemotherapy and posterior laparoscopic gas-
trectomy and D2 lymphadenectomy. Post-operative evolution
was successful. An upper endoscopy examination 5 months later
revealed a neoplastic anastomotic recurrence. An extension
study showed no metastatic lesions. A resection of the oesopha-
gojejunal anastomosis with a new oesophagojejunal anastomo-
sis was performed without further complications.
In September 2018, a follow-up PET-CT detected a new
anastomotic recurrence. The case was discussed by the
Esophagogastric Tumours Committee, who decided to per-
form chemoradiotherapy prior to the following surgery. A to-
tal oesophagectomy with right-colon interposition with a
cervical end-to-end hand-sewn oesophago-ileal anastomosis
was performed 4 months later. On the fifth post-operative
day, a cervical fistula appeared (Figure 1A) and a thoracic CT
scan identified a 7-cm mediastinal abscess (Figure 1B). The
clinical stability of the patient allowed conservative treat-
ment with intravenous antibiotics and nutritional support by
a jejunostomy tube.
Despite these measures, the anastomotic leak persisted for
the next 2 months with a daily output of >500 mL. As the leak-
age persisted with a large cavity and high-output, in April 2019,
E-Vac therapy with the Endo-SPONGE system (B. Braun
Submitted: 7 December 2019; Revised: 29 January 2020; Accepted: 12 June 2020
VC The Author(s) 2020. Published by Oxford University Press and Sixth Affiliated Hospital of Sun Yat-sen University
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact journals.permissions@oup.com
481
Gastroenterology Report, 8(6), 2020, 481–483
doi: 10.1093/gastro/goaa036
Advance Access Publication Date: 20 July 2020
Brief Report
Melsungen AG, Melsungen, Germany) was proposed. The
sponge was placed in the cavity with a regular gastroscope un-
der general endotracheal anaesthesia (Figure 1C). It was con-
nected to a continuous negative pressure of 80–100 mmHg.
Initially, the endosponge was replaced every 3 days, then every
10 days and every 15 days, until the complete sealing of the fis-
tula. The total number of different E-Vac therapy exchanges re-
quired was seven.
On the 18th day after the E-Vac therapy was applied, an
upper endoscopy showed the apparition of granulation tissue
and an 80% decrease in cavity size. Two weeks later, a barium
swallow demonstrated correct downstream flow without ste-
nosis or evidence of leaks (Figure 1D). Oral liquid diet was
started with good toleration and no further complications
occurred.
Discussion
Colon interposition as an oesophageal reconstruction after
oesophageal resection is a complex surgical technique that is
associated with major complications. In high-volume centres,
the rate of cervical anastomotic leakage, reported as a conse-
quence of colon interposition, achieves 46%, with an operative
mortality that reaches 17% [2, 3].
Traditionally, if conduit necrosis is ruled out and the patient is
clinically stable, conservative medical management is the usual
treatment for these complications. However, open drainage of the
wound, intravenous antibiotic therapy, and nil per oral is some-
times ineffective and substantially prolongs hospital stay.
The case reported shows an exceptional clinical situation.
While experience with E-Vac therapy in upper-gastrointestinal
disorders is increasing, the majority of the published studies
focus on the use of this device for the treatment of iatrogenic or
spontaneous oesophageal perforations. Nevertheless, the E-Vac
has also demonstrated efficacy in anastomotic leaks after
surgery, especially in intrathoracic anastomosis leaks after
Ivor-Lewis oesophagectomy [3–9].
Evidence published on the management of cervical fistulas
after oesophageal surgery is scarce. Recently, Min et al. [10]
reported the first seven cases of cervical anastomosis leaks
successfully managed with E-Vac therapy. However, none of
them occurred after a cervical oesophagoileostomy for oesopha-
geal reconstruction using the terminal ilium and right colon.
Limitations that have been attributed to this endoscopic
treatment are the need for hospitalization to perform the
procedure, the repeated endoscopic examinations, and the cost
of the material required. On the other hand, the achievement
of several endoscopies during the process allowed us to assess
the evolution of the defect, to irrigate, and to debride the cavity
until its complete closure.
In our case, the use of E-Vac therapy shortened the hospital
stay compared to conservative treatment, allowing the
Figure 1. A cervical anastomostic leakage cured with endoscopic vacuum device. (A) Cervical oesophagoileostomy fistula after total oesophagectomy with right-colon
interposition. (B) Thoracic CT scan showing mediastinal collection with extra-luminal contrast leakage. (C) Endoscopic vacuum (E-Vac) device placement. (D) Post E-
Vac therapy swallow test showing correct downstream flow through the cervical anastomosis, without leakage or other complications.
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successfully closure of the cervical fistula at Day 21 after the be-
ginning of the E-Vac therapy, with optimal functional results.
The duration of treatment until the closure of the fistula in our
case was similar to that published in other series.
Although the nature of the series published to date is
retrospective and heterogeneous due to different types of anas-
tomosis and localization, E-Vac therapy is positioning itself as a
good therapeutic option for the management of anastomotic
leakages in upper-gastrointestinal surgery. Further randomized
studies are needed to include this device in the multidiscipli-
nary algorithm and standardize treatment guidelines of these
major complications.
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